Merck Picks Up Another Win In Fosamax Bellwether

Law360, New York (November 19, 2010, 7:20 PM EST) -- Jurors returned a verdict Friday in favor of Merck & Co. Inc. in one of a handful of bellwether cases alleging the company’s osteoporosis drug Fosamax can cause bone rotting in patients’ jaws, marking the third win for Merck out of four such cases.

The jury delivered its verdict in the case filed by Judith Graves after just a few hours of deliberations Friday in the U.S. District Court for the Southern District of New York, finding that the company is not responsible for her alleged...
To view the full article, register now.




Case Information

Case Title

Graves v. Merck & Co., Inc.

Case Number



New York Southern

Nature of Suit

Personal Inj. Prod. Liability


John F. Keenan

Date Filed

July 21, 2006

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.